X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1533) 1533
Conference Proceeding (67) 67
Publication (45) 45
Patent (30) 30
Book Chapter (23) 23
Book Review (9) 9
Book / eBook (3) 3
Magazine Article (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (569) 569
male (340) 340
female (338) 338
middle aged (237) 237
adult (186) 186
endocrinology & metabolism (183) 183
index medicus (174) 174
aged (142) 142
risk factors (123) 123
type 2 diabetes (111) 111
diabetes mellitus, type 2 - drug therapy (96) 96
medicine, general & internal (90) 90
hypoglycemic agents - therapeutic use (89) 89
diabetes (87) 87
child (85) 85
diabetes mellitus, type 2 - blood (79) 79
adolescent (67) 67
double-blind method (63) 63
child, preschool (62) 62
risk (62) 62
chemistry (57) 57
diabetes mellitus, type 2 - complications (55) 55
blood glucose - metabolism (53) 53
clinical neurology (52) 52
glucose (52) 52
insulin (51) 51
medicine & public health (51) 51
pediatrics (50) 50
treatment outcome (50) 50
triglycerides - blood (49) 49
analysis (48) 48
research (47) 47
internal medicine (46) 46
mellitus (46) 46
metabolic syndrome (46) 46
mortality (46) 46
chemistry, physical (45) 45
drug therapy, combination (45) 45
follow-up studies (44) 44
infant (44) 44
myocardial-infarction (44) 44
insulin resistance (43) 43
cardiovascular-disease (42) 42
drug therapy (42) 42
cardiovascular disease (41) 41
glucose tolerance test (41) 41
hyperglycemia (41) 41
cardiac & cardiovascular systems (40) 40
pharmacology & pharmacy (40) 40
atherosclerosis (39) 39
disease (39) 39
chemistry, organic (38) 38
glycemic control (38) 38
catalysis (37) 37
insulin - blood (37) 37
prospective studies (37) 37
blood glucose - analysis (36) 36
enzymes (36) 36
acarbose (35) 35
cardiovascular diseases (34) 34
care and treatment (34) 34
hypertension (34) 34
prevention (34) 34
therapy (34) 34
animals (33) 33
chemistry, multidisciplinary (33) 33
hypoglycemic agents - administration & dosage (33) 33
hypoglycemic agents - adverse effects (33) 33
obesity (33) 33
biochemistry & molecular biology (32) 32
diabetes mellitus, type 2 - physiopathology (32) 32
glycated hemoglobin a - metabolism (32) 32
lipids - blood (32) 32
body weight (31) 31
time factors (31) 31
cholesterol - blood (30) 30
coronary-heart-disease (30) 30
dextrose (30) 30
diabetes mellitus (30) 30
cardiovascular diseases - prevention & control (29) 29
diabetes therapy (29) 29
risk-factors (29) 29
blood pressure (28) 28
clinical trials (28) 28
pioglitazone (28) 28
thiazolidinediones - therapeutic use (28) 28
abridged index medicus (27) 27
body mass index (27) 27
health aspects (27) 27
insulin-resistance (27) 27
fasting (26) 26
genetics & heredity (26) 26
cardiovascular diseases - epidemiology (25) 25
cholesterol (25) 25
glycated hemoglobin a - analysis (25) 25
magnetic resonance imaging (25) 25
metallurgy (25) 25
insulin sensitivity (24) 24
intima-media thickness (24) 24
metabolism (24) 24
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1142) 1142
German (462) 462
French (13) 13
Chinese (3) 3
Spanish (2) 2
Danish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catalysis Today, ISSN 0920-5861, 2006, Volume 117, Issue 1, pp. 279 - 283
Redox metals such as Ti, Co, Fe and Cr are incorporated into the framework of TUD-1 (a three-dimensional mesoporous silicate) and characterized by means of... 
TUD-1 | Oxidation | Mesoporous materials | Cyclohexane | oxidation | CHEMISTRY, PHYSICAL | CO-TUD-1 | AIR | CATALYST | ENGINEERING, CHEMICAL | SIEVES | mesoporous materials | CHEMISTRY, APPLIED | cyclohexane | MOLECULAR-OXYGEN | COBALT | Carbocyclic compounds | Transition metal compounds | Oxidation-reduction reaction | Silicates | Chemical properties | Leaching
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article